SELLAS Life Sciences (SLS) Operating Leases (2019 - 2026)
SELLAS Life Sciences (SLS) posted Operating Leases of $157,000 for Q2 2026, unchanged from $157,000 a year earlier and down 49.2% from the prior quarter.
Powered by 
Analysis
SELLAS Life Sciences (SLS) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, SELLAS Life Sciences' Operating Leases came in at $457,000, unchanged from FY2024.
- Annual Operating Leases shows a five-year compound annual growth rate of -11.1% (FY2020 to FY2025).
- In prior years, SELLAS Life Sciences' Operating Leases was $457,000 in FY2024 (-0.7%), $460,000 in FY2023 (-19.7%), $573,000 in FY2022 (-6.1%) and $610,000 in FY2021 (-26.1%).
- Quarterly Operating Leases has run from a low of $157,000 in Q2 2025 to a high of $883,000 in Q1 2022 over five years.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q1 2022, with growth of 13.9%; the weakest was Q3 2023, with a decline of 73.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | SELLAS Life Sciences | 2.34 Bn | 2.34 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 157,000.00 |
| Mar 31, 2026 | 309,000.00 |
| Dec 31, 2025 | 457,000.00 |
| Jun 30, 2025 | 157,000.00 |
| Mar 31, 2025 | 309,000.00 |
| Dec 31, 2024 | 457,000.00 |
| Jun 30, 2024 | 161,000.00 |
| Mar 31, 2024 | 313,000.00 |
| Dec 31, 2023 | 460,000.00 |
| Sep 30, 2023 | 178,000.00 |
| Jun 30, 2023 | 302,000.00 |
| Mar 31, 2023 | 422,000.00 |
| Dec 31, 2022 | 573,000.00 |
| Sep 30, 2022 | 680,000.00 |
| Jun 30, 2022 | 783,000.00 |
| Mar 31, 2022 | 883,000.00 |
| Dec 31, 2021 | 610,000.00 |
| Sep 30, 2021 | 667,000.00 |
| Jun 30, 2021 | 721,000.00 |
| Mar 31, 2021 | 775,000.00 |
API Access
SELLAS Life Sciences Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=SLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "SLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=SLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();